You are currently viewing a new version of our website. To view the old version click .

LabMed, Volume 2, Issue 1

March 2025 - 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Article
  • Open Access
1 Citations
5,394 Views
9 Pages

14 March 2025

The objective of this study was to assess the performance characteristics of the new automated haematology analyser from Sysmex Corporation, the Sysmex XR-Series, compare its performance to the Sysmex XN-Series through method comparison, and compare...

  • Article
  • Open Access
1 Citations
4,769 Views
12 Pages

Impact of Tube Additives on Baseline Cell-Free DNA, Blood Nuclease Activity, and Cell-Free DNA Degradation in Serum and Plasma Samples: A Comparative Study

  • Gustavo Barcelos Barra,
  • Ticiane Henriques Santa Rita,
  • Rafael Henriques Jácomo and
  • Lídia Freire Abdalla Nery

3 March 2025

Cell-free DNA (cfDNA) analysis is a pivotal tool in non-invasive diagnostics, including cancer monitoring and prenatal testing. However, the preanalytical phase, particularly the choice of anticoagulant, significantly impacts cfDNA integrity and yiel...

  • Article
  • Open Access
2,626 Views
11 Pages

20 February 2025

Recent initiatives have discouraged the treatment of asymptomatic bacteriuria in specific patient populations due to its lack of clinical benefit, no improvement in morbidity or mortality, and its contribution to antibiotic overuse. This study aimed...

  • Case Report
  • Open Access
1,438 Views
9 Pages

15 January 2025

Acute promyelocytic leukemia (APML) is one of the most curable leukemia subtypes, where the majority of patients achieve complete remission and also deep molecular remission after therapy, characterized by a PCR-undetectable state. Similarly, chronic...

  • Article
  • Open Access
1 Citations
1,972 Views
14 Pages

Validation of AIA-360 for Determination of Presepsin: A Useful Tool for the Diagnosis of Sepsis at the Emergency Department

  • Alfredo Giovannelli,
  • Massimo Pieri,
  • Eleonora Nicolai,
  • Martina Pelagalli,
  • Cinzia Calabrese,
  • Flaminia Tomassetti,
  • Jacopo Maria Legramante,
  • Alessandro Terrinoni,
  • Sergio Bernardini and
  • Marilena Minieri

25 December 2024

Sepsis is a life-threatening condition, and clinicians should diagnose it as soon as possible to enable rapid intervention. The study aims to validate the AIA-360 Presepsin (PSEP) test for its use in determination in the diagnosis of septic patients...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
LabMed - ISSN 2813-9038